Vaxcyte Inc (PCVX)
74.60
-0.85
(-1.13%)
USD |
NASDAQ |
May 17, 16:00
74.60
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Market Cap: 8.113B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 8.113B |
| May 16, 2024 | 8.209B |
| May 15, 2024 | 7.793B |
| May 14, 2024 | 7.325B |
| May 13, 2024 | 7.148B |
| May 10, 2024 | 7.092B |
| May 09, 2024 | 7.134B |
| May 08, 2024 | 7.266B |
| May 07, 2024 | 7.346B |
| May 06, 2024 | 7.224B |
| May 03, 2024 | 7.174B |
| May 02, 2024 | 7.020B |
| May 01, 2024 | 6.929B |
| April 30, 2024 | 6.585B |
| April 29, 2024 | 6.638B |
| April 26, 2024 | 6.604B |
| April 25, 2024 | 6.532B |
| April 24, 2024 | 6.558B |
| April 23, 2024 | 6.621B |
| April 22, 2024 | 6.700B |
| April 19, 2024 | 6.616B |
| April 18, 2024 | 6.593B |
| April 17, 2024 | 6.790B |
| April 16, 2024 | 6.769B |
| April 15, 2024 | 6.785B |
| Date | Value |
|---|---|
| April 12, 2024 | 6.730B |
| April 11, 2024 | 7.051B |
| April 10, 2024 | 6.802B |
| April 09, 2024 | 7.016B |
| April 08, 2024 | 6.970B |
| April 05, 2024 | 6.959B |
| April 04, 2024 | 6.891B |
| April 03, 2024 | 7.080B |
| April 02, 2024 | 7.007B |
| April 01, 2024 | 7.257B |
| March 28, 2024 | 7.405B |
| March 27, 2024 | 7.426B |
| March 26, 2024 | 7.309B |
| March 25, 2024 | 7.195B |
| March 22, 2024 | 7.288B |
| March 21, 2024 | 7.333B |
| March 20, 2024 | 7.494B |
| March 19, 2024 | 7.328B |
| March 18, 2024 | 7.376B |
| March 15, 2024 | 7.556B |
| March 14, 2024 | 7.510B |
| March 13, 2024 | 7.941B |
| March 12, 2024 | 7.764B |
| March 11, 2024 | 7.616B |
| March 08, 2024 | 7.880B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
845.18M
Minimum
May 10 2021
8.786B
Maximum
Feb 27 2024
2.810B
Average
1.656B
Median
Market Cap Benchmarks
| Apellis Pharmaceuticals Inc | 5.014B |
| Alnylam Pharmaceuticals Inc | 18.90B |
| Cytokinetics Inc | 6.242B |
| Exelixis Inc | 6.091B |
| Incyte Corp | 12.82B |
Market Cap Related Metrics
| Price to Book Value | 4.089 |
| Price | 74.60 |
| Earnings Yield | -6.57% |